
"I live each day with anxiety. I'm afraid of getting seriously hurt if I fall. If I can't stop the bleeding, surgery might be delayed... It's hard to extract teeth easily because of the difficulty in stopping the bleeding"...
If surgery is needed due to a sudden accident, but bleeding continues? The life of a person with hemophilia is filled with anxiety. Nevertheless, there is no fundamental treatment. Preventing bleeding is crucial, and only treatments for symptom relief are available. If blood flows from a wound, a hemophilia patient can become extremely panicked. Calm responses are necessary, and preparations for blood transfusions must be made. Is this how I have to live my whole life?
The health insurance premiums I struggle to pay...are used for those who live a hard life
The medical cost burden for patients with rare diseases like hemophilia, where stopping bleeding is difficult, has been reduced. It will be lowered to about half of the current level. On the 5th, the Ministry of Health and Welfare announced that it would gradually reduce the health insurance co-payment for rare and severe diseases, including hemophilia, from the current 10% to a maximum of 5%. Currently, the co-payment rate for general patients is 30%, and for cancer patients, it is 5%. However, the burden of medical costs for rare and severe intractable diseases, which are as painful as cancer, is 10%, making it significant. These are diseases that require lifelong treatment and management, but the costs are too high. This is why there have been continuous calls to strengthen support to the level of cancer patients.
Having to manage for a lifetime with an annual burden of 10.44 million won...how can I pay when living expenses are already tight?
The current average annual co-payment for hemophilia is about 10.44 million won. This is a tremendous burden for those who are already struggling with living expenses. Hemophilia occurs due to a congenital deficiency of blood coagulation factors. Types A and B of hemophilia account for more than 95% of all hemophilia cases. Many hemophilia cases arise from genetics, but 20-30% occur due to mutations without a family history. The bleeding symptoms of hemophilia B are more severe in children and adolescents than in adults. Among women with genetic factors, 10% may have mild symptoms but are at risk of bleeding.
People who have to live hard lives due to congenital conditions...1.3 million have at least had their burden reduced
Many children suffer from rare and severe intractable diseases. They have to live hard lives for their entire lives. They did not develop their diseases due to bad habits like smoking or poor eating habits, unlike adults. Parents are not to blame either. How many people are aware of genetics and mutations? The lives of families have also been a continuous struggle. Those without money have only been able to shed tears. The wall of rare and severe intractable diseases is too high, requiring lifelong hospital treatment and management. Many young couples have spent most of their hard-earned money on their children's medical expenses. With this government measure, about 1.3 million people are expected to have their burden reduced. There are about 453,000 rare disease patients in the country, and 844,000 patients with severe intractable diseases.
Gradual abolition of income and asset criteria for dependents of rare disease patients...strengthening medical cost support
The government has decided to strengthen medical cost support for patients with rare and severe intractable diseases. Starting in 2027, the income and asset criteria that were separately applied to dependents will be gradually abolished. This will expand medical cost support for low-income rare disease patients. Although the cases of rare and severe intractable diseases are different, current health insurance regional subscribers are charged health insurance premiums based not only on income but also on assets like homes. Retirees, who mostly own a single house, raise their voices, saying, "How can I sell my home, which I have cherished for decades, when I can barely make ends meet?" Of course, while they cannot be simply compared to patients with rare and severe intractable diseases, retirees also express dissatisfaction with being charged health insurance premiums on the assets they have worked hard to accumulate throughout their lives.
What rare and severe intractable diseases does our family suffer from?
The Ministry of Health and Welfare will strengthen the special support for rare and severe intractable diseases that require significant medical cost burdens and continuous treatment and management to the level of cancer patients. The general health insurance co-payment rate (for outpatient treatment) is 30%, but for rare and severe intractable diseases that are eligible for special support, it is 10%, and for cancer, it is only 5%. In the future, the co-payment rate for health insurance for rare and severe intractable diseases will be gradually reduced to 5%. It will be reviewed and finalized whether to apply uniformly or to differentiate the reduction by disease. Currently, the average annual co-payment for special support diseases is about 570,000 won for rare diseases and about 860,000 won for severe intractable diseases. In particular, the co-payment for hemophilia is 10.44 million won, for blood dialysis is 3.14 million won, and for peritoneal dialysis is 1.72 million won. There is a significant difference in co-payment amounts among diseases. A reduction plan will be established in the first half of this year and implemented in the second half.
Eliminating additional tests and making re-registration procedures patient-centered...I don't regret paying health insurance premiums
Rare and severe intractable diseases often have a family history and are difficult to cure. Reflecting the opinions from the medical field, the re-registration procedure that had to be done every five years will also be changed. Until now, for 312 rare and severe intractable diseases, separate test results were required for re-registration for special support, but in the future, this will no longer be necessary. Starting in January, the Ministry of Health and Welfare has eliminated the requirement for test results for re-registration for nine diseases, including Charcot-Marie-Tooth disease. This will be expanded to apply to all diseases in the future.
To provide urgent treatment for patients, a rapid listing of treatment drugs on health insurance will also be established. Starting in the first half of this year, the health insurance application period for rare disease treatments will be shortened from 240 days to within 100 days. The government will lead the purchase and supply of self-treatment medicines that patients previously bought directly from abroad. The lives of those who are born with the burden of rare and severe intractable diseases are hard. They have no fault, such as smoking... My heart warms at the government's announcement that the health insurance premiums I struggle to pay are used for them.